Skip to main content
. 2020 Mar 1;11(1):261–271. doi: 10.1080/21655979.2020.1735611

Figure 1.

Figure 1.

Immunolocalization of FAM136A in human lung carcinoma. a. strong immunoreactivity of FAM136A was widely detected in lung carcinoma b. FAM136A was immunolocalized mainly in the cytoplasm of lung carcinoma cells. c. FAM136A was positive in the in situ lesions of lung carcinoma, but not in the non-neoplastic mucosal epithelium adjacent to the carcinoma (*).d. FAM136A was weakly detected in non-neoplastic mucosal epithelium. e.Negative control for FAM136A immunohistochemistry. Scale bar: 20 μm.